表紙
市場調查報告書
商品編碼
1040490

抗真菌劑的全球市場:2021年∼2027年

Global Antifungal Agents Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球抗真菌劑的市場規模在預測期間內預計將以約3.5%大幅度的年複合成長率成長。曲霉病和念珠菌病等傳染病的流行正在顯著推動市場。市場增長的另一個主要驅動力是真菌感染髮生率的增加。

醫療保健的進步正在推動市場的增長,包括用於治療真菌疾病的藥物發現以及公共和私營部門的共同努力。此外,新興國家的發展機遇,如先進醫療基礎設施的發展,有望推動市場增長。

本報告提供全球抗真菌劑市場相關調查,提供市場概要,以及各類藥物,各劑型,各給藥途徑,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的開發
  • 重要策略分析
  • COVID-19對主要企業的影響

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球抗真菌劑市場,各類藥物
    • Polyenes
    • Echinocandins
    • 丙烯基胺
    • Azole
  • 全球抗真菌劑市場,各劑型
    • 粉末
    • 軟膏
    • 藥物
  • 全球抗真菌劑市場,各給藥途徑
    • 非口服
    • 局部
    • 口服

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories, Inc.
  • Astellas Pharma Inc.
  • Basilea Pharmaceutica Ltd.
  • Bayer Healthcare LLC
  • Bristol-Myers Squibb Co.
  • Cadila Healthcare Ltd.
  • Cosmo Pharmaceuticals N.V.
  • Dr. Reddy's Laboratories Ltd.
  • Gilead Sciences, Inc.
  • Janssen Pharmaceutica NV
  • Mayne Pharma Group Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi-Aventis Groupe SA
  • SCYNEXIS, Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
目錄
Product Code: OMR2024041

Global Antifungal Agents Market Size, Share &Trends Analysis Report, By Drug Class (Polyene, Echinocandins, Allylamines, and Azole), By Dosage Type (Powder, Ointment, and Drugs), By Route of Administration (Parenteral, Topical, and Oral), Forecast Period 2021-2027

The global antifungal agents market is estimated to grow at a significant CAGR of nearly 3.5% during the forecast period. The rise in the prevalence of infections such as aspergillosis and candidiasis has been significantly driving the market. Another major factor propelling the growth of the market include the rise in incidences of fungal infection. As per the Centers for Disease Control and Prevention (CDC), in 2017, there were nearly 23,000 cases of invasive candidiasis in the US

Fungal diseases cost $7.2 billion in direct medical costs in 2017. 75,000 hospitalizations and nearly 9 million outpatient visits were reported due to fungal diseases in 2017. This, in turn, is encouraging the demand for antifungal agents that can fight fungal infection without damaging cells of the body. Furthermore, medical advancements that include ongoing drug discovery and public-private initiatives to treat fungal diseases are driving market growth. Additionally, evolving opportunities in emerging economies such as the development of advanced healthcare infrastructure facilities are also expected to propel the growth of the market

The COVID-19 pandemic has led to an increased demand for anti-fungal agents in the market. The patients hospitalized for the treatment of COVID-19 are at risk of healthcare-associated infections including candidemia or bloodstream infections that are caused by Candida. Additionally, the rise in the number of cases of black fungus, white fungus, and pink fungus has been increasing the demand for antifungal agents.

The global antifungal agents market is segmented based on drug class, dosage type, and route of administration. Based on drug class, it is segmented into polyene, echinocandins, allylamines, azole. Based on dosage type, it is further classified into powder, ointment, and drugs Based on the route of administration, it is further classified into parenteral, topical, and oral

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to witness a significant share in the market owing to the potential healthcare spending and rising prevalence of fungal diseases in the region. Furthermore, specialized drug discovery for these diseases in the region also drives the market growth in the North American market. In addition, the presence of established pharmaceutical companies, which are consistently focusing on extensive commercialization of their drugs and enhancing their geographical reach, is anticipated to be a key factor escalating the growth of the market in the region

Whereas, Asia-Pacific is expected to be the fastest-growing region in the market. The attributable factors include improving healthcare infrastructure, rising incidences of black fungus and other fungi in the country such as India, and rising medical tourism in the region. Thus, the global players are focusing on high R&D investment as well as commercializing branded drugs at a relatively lower price in the region

Major players in the market include Abbott Laboratories, Inc., Pfizer Inc., and Bayer AG, among others. Partnership &collaborations, product launches, and mergers and acquisitions are some crucial strategies adopted by the market players to gain a competitive advantage over their competitors.

Research Methodology

The market study of the global antifungal agents market is incorporated by extensive primary and secondary research conducted by the research team at OMR Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market

Whitepapers, research papers, and news blogs

Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Antifungal Agents Market Research and Analysis, By Drug Class

Global Antifungal Agents Market Research and Analysis, By Dosage Type

Global Antifungal Agents Market Research and Analysis, By Route of Administration

The Report Covers

Comprehensive research methodology of the global antifungal agents market

This report also includes a detailed and extensive market overview with key analyst insights

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations

Analysis of regional regulations and other government policies impacting the global antifungal agents market

Insights about market determinants that are stimulating the global antifungal agents market

Detailed and extensive market segments with the regional distribution of forecasted revenues

Extensive profiles and recent developments of market players

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Antifungal Agents Industry
  • Recovery Scenario of Global Antifungal Agents Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Antifungal Agents Market, by Drug Class
    • 5.1.1. Polyene
    • 5.1.2. Echinocandins
    • 5.1.3. Allylamines
    • 5.1.4. Azole
  • 5.2. Global Antifungal Agents Market, by Dosage Type
    • 5.2.1. Powder
    • 5.2.2. Ointment
    • 5.2.3. Drugs
  • 5.3. Global Antifungal Agents Market, by Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Topical
    • 5.3.3. Oral

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. Astellas Pharma Inc.
  • 7.3. Basilea Pharmaceutica Ltd.
  • 7.4. Bayer Healthcare LLC
  • 7.5. Bristol-Myers Squibb Co.
  • 7.6. Cadila Healthcare Ltd.
  • 7.7. Cosmo Pharmaceuticals N.V.
  • 7.8. Dr. Reddy's Laboratories Ltd.
  • 7.9. Gilead Sciences, Inc.
  • 7.10. Janssen Pharmaceutica NV
  • 7.11. Mayne Pharma Group Ltd.
  • 7.12. Merck & Co., Inc.
  • 7.13. Pfizer Inc.
  • 7.14. Sanofi-Aventis Groupe SA
  • 7.15. SCYNEXIS, Inc.
  • 7.16. Sumitomo Dainippon Pharma Co., Ltd.
  • 7.17. Sun Pharmaceutical Industries Ltd.
  • 7.18. Teva Pharmaceutical Industries Ltd.
  • 7.19. Viatris Inc.

LIST OF TABLES

  • 1. GLOBAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2020-2027($ MILLION)
  • 3. GLOBAL POLYENE ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 4. GLOBAL ECHINOCANDINS ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 5. GLOBAL ALLYLAMINES ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 6. GLOBAL AZOLE ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 7. GLOBAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2020-2027($ MILLION)
  • 8. GLOBAL ANTIFUNGAL POWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 9. GLOBAL ANTIFUNGAL OINTMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 10. GLOBAL ANTIFUNGAL DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 11. GLOBAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027($ MILLION)
  • 12. GLOBAL PARENTERAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 13. GLOBAL TOPICAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 14. GLOBAL ORAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 15. GLOBAL ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027($ MILLION)
  • 16. NORTH AMERICAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 17. NORTH AMERICAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2020-2027($ MILLION)
  • 18. NORTH AMERICAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2020-2027($ MILLION)
  • 19. NORTH AMERICAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027($ MILLION)
  • 20. EUROPEAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 21. EUROPEAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2020-2027($ MILLION)
  • 22. EUROPEAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2020-2027($ MILLION)
  • 23. EUROPEAN ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027($ MILLION)
  • 24. ASIA-PACIFIC ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 25. ASIA-PACIFIC ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2020-2027($ MILLION)
  • 26. ASIA-PACIFIC ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2020-2027($ MILLION)
  • 27. ASIA-PACIFIC ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027($ MILLION)
  • 28. REST OF THE WORLD ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2020-2027($ MILLION)
  • 29. REST OF THE WORLD ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2020-2027($ MILLION)
  • 30. REST OF THE WORLD ANTIFUNGAL AGENTS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL ANTIFUNGAL AGENTS MARKET, 2020-2027($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL ANTIFUNGAL AGENTS MARKET BY SEGMENT, 2020-2027($ MILLION)
  • 3. RECOVERY OF GLOBAL ANTIFUNGAL AGENTS MARKET, 2021-2027(%)
  • 4. GLOBAL ANTIFUNGAL AGENTS MARKET SHARE BY DRUG CLASS, 2020 VS 2027 (%)
  • 5. GLOBAL ANTIFUNGAL AGENTS MARKET SHARE BY DOSAGE TYPE, 2020 VS 2027 (%)
  • 6. GLOBAL ANTIFUNGAL AGENTS MARKET SHARE BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (%)
  • 7. GLOBAL ANTIFUNGAL AGENTS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL POLYENE ANTIFUNGAL AGENTS MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 9. GLOBAL ECHINOCANDINS ANTIFUNGAL AGENTS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL ALLYLAMINES ANTIFUNGAL AGENTS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL AZOLE ANTIFUNGAL AGENTS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL ANTIFUNGAL POWDER MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL ANTIFUNGAL OINTMENTS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL ANTIFUNGAL DRUGS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL PARENTERAL ANTIFUNGAL AGENTS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL TOPICAL ANTIFUNGAL AGENTS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL ORAL ANTIFUNGAL AGENTS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 18. US ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. CANADA ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. UK ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. FRANCE ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. GERMANY ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. ITALY ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. SPAIN ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. REST OF EUROPE ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. INDIA ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. CHINA ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. JAPAN ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. SOUTH KOREA ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. REST OF ASIA-PACIFIC ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. REST OF THE WORLD ANTIFUNGAL AGENTS MARKET SIZE, 2020-2027 ($ MILLION)